These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 15980363)

  • 1. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.
    Bruttin A; Brüssow H
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2874-8. PubMed ID: 15980363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Kutter E; Sarker S; Brüssow H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2558-69. PubMed ID: 15215109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh.
    Sarker SA; Sultana S; Reuteler G; Moine D; Descombes P; Charton F; Bourdin G; McCallin S; Ngom-Bru C; Neville T; Akter M; Huq S; Qadri F; Talukdar K; Kassam M; Delley M; Loiseau C; Deng Y; El Aidy S; Berger B; Brüssow H
    EBioMedicine; 2016 Feb; 4():124-37. PubMed ID: 26981577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Dillmann ML; Kutter E; Qadri F; Sarker SA; Brüssow H
    J Bacteriol; 2004 Dec; 186(24):8287-94. PubMed ID: 15576777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh.
    Sarker SA; Berger B; Deng Y; Kieser S; Foata F; Moine D; Descombes P; Sultana S; Huq S; Bardhan PK; Vuillet V; Praplan F; Brüssow H
    Environ Microbiol; 2017 Jan; 19(1):237-250. PubMed ID: 27750388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.
    Weiss M; Denou E; Bruttin A; Serra-Moreno R; Dillmann ML; Brüssow H
    Virology; 2009 Oct; 393(1):16-23. PubMed ID: 19699505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T4 phages against Escherichia coli diarrhea: potential and problems.
    Denou E; Bruttin A; Barretto C; Ngom-Bru C; Brüssow H; Zuber S
    Virology; 2009 May; 388(1):21-30. PubMed ID: 19339031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From bench to bed and back again: phage therapy of childhood Escherichia coli diarrhea.
    Sarker SA; Brüssow H
    Ann N Y Acad Sci; 2016 May; 1372(1):42-52. PubMed ID: 27197768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.
    Sarker SA; McCallin S; Barretto C; Berger B; Pittet AC; Sultana S; Krause L; Huq S; Bibiloni R; Bruttin A; Reuteler G; Brüssow H
    Virology; 2012 Dec; 434(2):222-32. PubMed ID: 23102968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects.
    McCallin S; Alam Sarker S; Barretto C; Sultana S; Berger B; Huq S; Krause L; Bibiloni R; Schmitt B; Reuteler G; Brüssow H
    Virology; 2013 Sep; 443(2):187-96. PubMed ID: 23755967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli detection by GFP-labeled lysozyme-inactivated T4 bacteriophage.
    Tanji Y; Furukawa C; Na SH; Hijikata T; Miyanaga K; Unno H
    J Biotechnol; 2004 Oct; 114(1-2):11-20. PubMed ID: 15464594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice.
    Tanji Y; Shimada T; Fukudomi H; Miyanaga K; Nakai Y; Unno H
    J Biosci Bioeng; 2005 Sep; 100(3):280-7. PubMed ID: 16243277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli O149 infection of pigs.
    Jamalludeen N; Johnson RP; Shewen PE; Gyles CL
    Vet Microbiol; 2009 Apr; 136(1-2):135-41. PubMed ID: 19058927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro.
    Ryan EM; Alkawareek MY; Donnelly RF; Gilmore BF
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):395-8. PubMed ID: 22524448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections.
    Nishikawa H; Yasuda M; Uchiyama J; Rashel M; Maeda Y; Takemura I; Sugihara S; Ujihara T; Shimizu Y; Shuin T; Matsuzaki S
    Arch Virol; 2008; 153(3):507-15. PubMed ID: 18188500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of bacteriophage T4 in a starved Escherichia coli culture: evidence for the presence of phage subpopulations.
    Golec P; Wiczk A; Łoś JM; Konopa G; Węgrzyn G; Łoś M
    J Gen Virol; 2011 Apr; 92(Pt 4):997-1003. PubMed ID: 21177930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.
    Graham DY; Estes MK; Gentry LO
    Gastroenterology; 1983 Nov; 85(5):1017-22. PubMed ID: 6352386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
    Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA response of BALB/c mice to orally administered Salmonella typhimurium flagellin-displaying T2 bacteriophages.
    Synnott A; Ohshima K; Nakai Y; Tanji Y
    Biotechnol Prog; 2009; 25(2):552-8. PubMed ID: 19334277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.